Cited by 313Tryptophan and brain disordersTreatment of Major DepressionStress Responses and Cortisol

The DOI matches its Crossref record; 226 of the 229 references it cites were found in a registry or an index, and 2 are not checked yet; none of the 212 sources its claims cite is checked for support yet.

Cytokine Research in Depression: Principles, Challenges, and Open Questions

Open access

Abstract

2), pro-inflammatory or anti-inflammatory cytokines of patients with a depressive disorder to those of healthy controls. Additionally, multiple longitudinal studies have investigated cytokine levels during antidepressant treatment. According to the current literature, it seems that peripheral levels of interleukin (IL)-6, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF)-α are elevated and that interferon (IFN)-γ levels are lower in patients with depression compared to healthy controls. However, the overlap of cytokine values between acutely depressed patients, remitted and recovered patients and healthy controls is considerable. Thus, the discriminative power of cytokine concentrations between depressed and non-depressed people is likely weak. Treatment with certain antidepressants appears to decrease peripheral levels of IL-6, IL-10, and TNF-α. However, weight gain-inducing psychopharmacological substances, such as the antidepressant mirtazapine, have been reported to potentially increase the production of pro-inflammatory cytokines. Even though cytokines are often discussed as biomarkers for depression, they have also been shown to be altered in other psychiatric disorders. Moreover, many environmental, social, psychological, biological, and medical factors are also associated with cytokine changes. Thus, cytokine alterations seem extremely unspecific. The interpretation of the results of these studies remains a challenge because it is unknown which type of cells are most responsible for cytokine changes measured in the blood nor have the main target cells or target tissues been identified. The same cytokine can be produced by multiple cell types, and the same cell can produce various cytokines. Additionally, redundancy, synergy, antagonism, and signaling cascades of cytokine signaling must be considered. Cytokines might not be associated with the diagnosis of depression according to the currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses. Therefore, the currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research.

Checked 2026-10-06 · 2 references not checked yet

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This narrative review explains cytokine biology and critically assesses cytokine research in depression, concluding that peripheral cytokine alterations are statistically associated with depression but too overlapping and unspecific to serve as individual biomarkers. It argues that current diagnostic categories may be a poor starting point for psychiatric cytokine research.

Key findings

  • Meta-analytic evidence cited by the review indicates that patients with depression have elevated serum/plasma IL-6, IL-10, IL-12, IL-13, and TNF-α, and lower IFN-γ, compared with healthy controls; however, cytokine values overlap considerably between depressed, remitted/recovered, and healthy individuals.
  • A cited meta-analysis of 45 longitudinal studies and more than 1,500 patients found that antidepressant treatment overall decreases peripheral IL-6, IL-10, and TNF-α, but the review notes that reductions in peripheral inflammation were not shown to be associated with antidepressant treatment response.
  • Cytokine alterations are not specific to depression: elevated TNF-α has also been found in PTSD, anorexia nervosa, and acute relapse of schizophrenia, and many environmental, social, psychological, biological, and medical factors are associated with cytokine changes.
  • In one cited study, mean TNF-α serum concentrations were 50.35 ± 78.01 pg/ml in depressed patients versus 33.80 ± 46.17 pg/ml in healthy controls, illustrating substantial within-group variation and overlapping ranges despite significant group differences.

Methods

  • Narrative review; the authors did not apply strict selection criteria, instead selecting articles based on how comprehensive, innovative, clearly written, and informative they were for in-depth understanding and critical debate.
  • Included original research, reviews, book chapters, and case reports; for the section on cytokine alterations in depression and other psychiatric disorders, they strictly included only the latest meta-analysis on cytokine levels for each diagnosis in the text and Table 2.
  • The review synthesizes literature on cytokine biology, immune-brain signaling, cytokine alterations in depression and other psychiatric disorders, risk factors, confounders, and antidepressant/psychotherapy effects.

Limitations

  • Stated: the review is narrative and did not use strict selection criteria; cytokine research shows conflicting results and high variance; it is often unclear which cells produce measured cytokines or which target cells/tissues are involved; cytokine alterations are extremely unspecific; current diagnostic systems may not be ideal for psychiatric cytokine research; few studies have measured cytokines in cerebrospinal fluid; and there is not enough literature to draw firm conclusions about the influence of certain antidepressants on peripheral cytokine levels in vivo.
  • Evident from the text: as a narrative review, it lacks a systematic search strategy, formal quality appraisal, and quantitative synthesis, so its conclusions depend on selected literature and cited meta-analyses rather than a reproducible systematic review process.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2019.00030

Cites

226 of 228 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 212 cited sources checked · 0 supported · 0 flagged

Show all 86 claims

  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 9
37 of 37
  • The paper relies on this without support.

    Both the obese and the elderly exhibit behavioral symptoms such as depression and cognitive dysfunction at an increased rate compared to the general population.

    “Both the obese and the elderly exhibit behavioral symptoms such as depression and cognitive dysfunction at an increased rate compared to the general population.”
  • The paper relies on this without support.

    People with depression exhibit heterogeneous sets of symptoms.

    “People with depression exhibit heterogeneous sets of symptoms.”
  • The authors state this as an assumption.

    Cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.

    “even though one would assume that cytokine concentrations in the cerebrospinal fluid might better reflect cytokine signaling in the brain than cytokine levels in the serum or plasma.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 229 references

1 of the 229 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Himmerich, 2014, Prävention psychischer Erkrankungen am Beispiel der Depression, 166
  2. Weschenfelder, 2012, The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems, Psychiatr Danub., 24, 112

Cited by

Sorted by citations

Items 301–313 of 313

Metadata

Authors
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B.
Affiliations
  • King's College London (GB)
  • Maidstone and Tunbridge Wells NHS Trust (GB)
  • Kings Health Partners (GB)
Corresponding author
Himmerich, Hubertus
Venue
Frontiers in Psychiatry
Published
2019-02-07
Volume
10
Pages
30-30
ISSN
1664-0640 (ISSN-L)
OpenAlex
W2912456649
Cited by
313
References
229
Citations by year
2026: 15 · 2025: 30 · 2024: 42 · 2023: 85 · 2022: 45 · 2021: 52 · 2020: 35 · 2019: 8
FWCI
2.16
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • South London and Maudsley NHS Foundation Trust
  • King's College London
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
depression, cytokines, inflammatory cytokines, anti-inflammatory cytokines, interleukin-6, IL-10, TNF-α, interferon-gamma, antidepressant treatment, mirtazapine, weight gain, biomarkers, cytokine signaling, depression subtypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review